Outset Medical, Inc.
OM
$4.62
-$0.07-1.49%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 27.86M | 28.87M | 29.43M | 31.42M | 29.75M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 27.86M | 28.87M | 29.43M | 31.42M | 29.75M |
| Cost of Revenue | 15.77M | 16.64M | 17.84M | 19.55M | 18.69M |
| Gross Profit | 12.10M | 12.23M | 11.59M | 11.87M | 11.07M |
| SG&A Expenses | 23.40M | 24.81M | 22.03M | 23.44M | 21.95M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 44.78M | 46.50M | 45.24M | 48.28M | 46.15M |
| Operating Income | -16.92M | -17.63M | -15.81M | -16.87M | -16.40M |
| Income Before Tax | -18.76M | -19.40M | -17.43M | -18.44M | -25.67M |
| Income Tax Expenses | 217.00K | 95.00K | 404.00K | 104.00K | 115.00K |
| Earnings from Continuing Operations | -18.98M | -19.49M | -17.84M | -18.54M | -25.78M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -18.98M | -19.49M | -17.84M | -18.54M | -25.78M |
| EBIT | -16.92M | -17.63M | -15.81M | -16.87M | -16.40M |
| EBITDA | -16.12M | -16.75M | -14.80M | -15.71M | -15.11M |
| EPS Basic | -1.03 | -1.09 | -1.00 | -1.05 | -3.66 |
| Normalized Basic EPS | -0.64 | -0.68 | -0.61 | -0.65 | -1.60 |
| EPS Diluted | -1.03 | -1.09 | -1.00 | -1.05 | -3.66 |
| Normalized Diluted EPS | -0.64 | -0.68 | -0.61 | -0.65 | -1.60 |
| Average Basic Shares Outstanding | 18.37M | 17.82M | 17.78M | 17.74M | 7.04M |
| Average Diluted Shares Outstanding | 18.37M | 17.82M | 17.78M | 17.74M | 7.04M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |